• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与α受体复合的白细胞介素-2的结构。

The structure of interleukin-2 complexed with its alpha receptor.

作者信息

Rickert Mathias, Wang Xinquan, Boulanger Martin J, Goriatcheva Natalia, Garcia K Christopher

机构信息

Departments of Microbiology and Immunology, and Structural Biology, Stanford University School of Medicine, 299 Campus Drive, Fairchild D319, Stanford, CA 94305-5124, USA.

出版信息

Science. 2005 Jun 3;308(5727):1477-80. doi: 10.1126/science.1109745.

DOI:10.1126/science.1109745
PMID:15933202
Abstract

Interleukin-2 (IL-2) is an immunoregulatory cytokine that binds sequentially to the alpha (IL-2Ralpha), beta (IL-2Rbeta), and common gamma chain (gammac) receptor subunits. Here we present the 2.8 angstrom crystal structure of a complex between human IL-2 and IL-2Ralpha, which interact in a docking mode distinct from that of other cytokine receptor complexes. IL-2Ralpha is composed of strand-swapped "sushi-like" domains, unlike the classical cytokine receptor fold. As a result of this domain swap, IL-2Ralpha uses a composite surface to dock into a groove on IL-2 that also serves as a binding site for antagonist drugs. With this complex, we now have representative structures for each class of hematopoietic cytokine receptor-docking modules.

摘要

白细胞介素-2(IL-2)是一种免疫调节细胞因子,它依次与α(IL-2Rα)、β(IL-2Rβ)和共同γ链(γc)受体亚基结合。在此,我们展示了人IL-2与IL-2Rα复合物的2.8埃晶体结构,它们以一种不同于其他细胞因子受体复合物的对接模式相互作用。IL-2Rα由链交换的“寿司样”结构域组成,不同于经典的细胞因子受体折叠结构。由于这种结构域交换,IL-2Rα利用一个复合表面对接至IL-2上的一个凹槽中,该凹槽也是拮抗剂药物的结合位点。有了这个复合物,我们现在拥有了每一类造血细胞因子受体对接模块的代表性结构。

相似文献

1
The structure of interleukin-2 complexed with its alpha receptor.与α受体复合的白细胞介素-2的结构。
Science. 2005 Jun 3;308(5727):1477-80. doi: 10.1126/science.1109745.
2
Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.白细胞介素-2与其α、β和γc受体的四元复合物结构。
Science. 2005 Nov 18;310(5751):1159-63. doi: 10.1126/science.1117893.
3
IL-2 induces conformational changes in its preassembled receptor core, which then migrates in lipid raft and binds to the cytoskeleton meshwork.白细胞介素-2 诱导其预先组装的受体核心发生构象变化,然后迁移到脂筏中并与细胞骨架网格结合。
J Mol Biol. 2010 Nov 12;403(5):671-92. doi: 10.1016/j.jmb.2010.08.056. Epub 2010 Sep 21.
4
Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sites.白细胞介素-2诱导白细胞介素-2受体α(IL-2Rα)表达:两个Stat5对接位点之间白细胞介素-2受体β链区域的重要作用。
Eur Cytokine Netw. 2002 Jul-Sep;13(3):331-9.
5
Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.与白细胞介素-1β复合的I型白细胞介素-1受体的晶体结构。
Nature. 1997 Mar 13;386(6621):190-4. doi: 10.1038/386190a0.
6
IL-3, IL-5, and GM-CSF signaling: crystal structure of the human beta-common receptor.白细胞介素-3、白细胞介素-5和粒细胞-巨噬细胞集落刺激因子信号传导:人β共同受体的晶体结构
Vitam Horm. 2006;74:1-30. doi: 10.1016/S0083-6729(06)74001-8.
7
Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor.人白细胞介素-10在1.6埃分辨率下的晶体结构及其与可溶性受体复合物的模型。
Protein Sci. 1996 Oct;5(10):1955-62. doi: 10.1002/pro.5560051001.
8
Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.白细胞介素-6/白细胞介素-6α受体/gp130复合物的六聚体结构与组装
Science. 2003 Jun 27;300(5628):2101-4. doi: 10.1126/science.1083901.
9
Compensatory energetic mechanisms mediating the assembly of signaling complexes between interleukin-2 and its alpha, beta, and gamma(c) receptors.介导白细胞介素-2与其α、β和γ(c)受体之间信号复合物组装的代偿性能量机制。
J Mol Biol. 2004 Jun 18;339(5):1115-28. doi: 10.1016/j.jmb.2004.04.038.
10
Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor alpha-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect.经改造以提高白细胞介素2(IL-2)受体α亚基亲和力的IL-2变体,由于细胞表面配体储存效应而表现出增强的效力。
Mol Pharmacol. 2004 Oct;66(4):864-9. doi: 10.1124/mol.66.4..

引用本文的文献

1
Engineering Fusion Proteins for Nanomedicine-Based Cytokine Therapy.用于基于纳米医学的细胞因子治疗的工程融合蛋白
Bioconjug Chem. 2025 Aug 20;36(8):1698-1708. doi: 10.1021/acs.bioconjchem.5c00182. Epub 2025 Jul 11.
2
Advances of oncolytic vaccinia viruses armed with interleukin in tumor therapy.携带白细胞介素的溶瘤痘苗病毒在肿瘤治疗中的研究进展
Front Oncol. 2025 May 21;15:1594621. doi: 10.3389/fonc.2025.1594621. eCollection 2025.
3
Unveiling alternative splicing dynamics in activated T lymphocytes and their implications for immune checkpoint blockade efficacy.
揭示活化T淋巴细胞中的可变剪接动态及其对免疫检查点阻断疗效的影响。
iScience. 2025 Apr 15;28(5):112434. doi: 10.1016/j.isci.2025.112434. eCollection 2025 May 16.
4
Directed disruption of IL2 aggregation and receptor binding sites produces designer biologics with enhanced specificity and improved production capacity.定向破坏白细胞介素-2的聚集和受体结合位点可产生具有更高特异性和更强生产能力的定制生物制剂。
Comput Struct Biotechnol J. 2025 Mar 4;27:1112-1123. doi: 10.1016/j.csbj.2025.03.002. eCollection 2025.
5
Regulating IL-2 Immune Signaling Function Via A Core Allosteric Structural Network.通过核心变构结构网络调节白细胞介素-2免疫信号功能
J Mol Biol. 2025 Jan 15;437(2):168892. doi: 10.1016/j.jmb.2024.168892. Epub 2024 Dec 9.
6
Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective and emerging trends.利用白细胞介素-2进行癌症和慢性感染的免疫治疗:历史视角与新趋势
Exp Mol Med. 2024 Sep;56(9):1900-1908. doi: 10.1038/s12276-024-01301-3. Epub 2024 Sep 2.
7
The JAK-STAT pathway: from structural biology to cytokine engineering.JAK-STAT 通路:从结构生物学到细胞因子工程。
Signal Transduct Target Ther. 2024 Aug 21;9(1):221. doi: 10.1038/s41392-024-01934-w.
8
"IL-2 immunotherapy for targeting regulatory T cells in autoimmunity".“针对自身免疫中的调节性 T 细胞的 IL-2 免疫疗法”。
Genes Immun. 2023 Oct;24(5):248-262. doi: 10.1038/s41435-023-00221-y. Epub 2023 Sep 23.
9
Identification of potent anti-immunogenic agents through virtual screening, 3D-QSAR studies, and in vitro experiments.通过虚拟筛选、3D-QSAR研究和体外实验鉴定强效抗免疫原性药物。
Mol Divers. 2024 Oct;28(5):2771-2782. doi: 10.1007/s11030-023-10709-4. Epub 2023 Aug 8.
10
Strategies to therapeutically modulate cytokine action.治疗性调节细胞因子作用的策略。
Nat Rev Drug Discov. 2023 Oct;22(10):827-854. doi: 10.1038/s41573-023-00746-x. Epub 2023 Aug 4.